Biomarkers for immune checkpoint inhibition in sarcomas – are we close to clinical implementation?
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Biomarkers for immune checkpoint inhibition in sarcomas – are we close to clinical implementation? ; volume:11 ; number:1 ; day:23 ; month:8 ; year:2023 ; pages:1-30 ; date:12.2023
Biomarker Research ; 11, Heft 1 (23.8.2023), 1-30, 12.2023
- Creator
-
Yiong, Chin Sern
Lin, Tzu Ping
Lim, Vivian Yujing
Toh, Tan Boon
Yang, Valerie Shiwen
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40364-023-00513-5
- URN
-
urn:nbn:de:101:1-2023110609375981095930
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Yiong, Chin Sern
- Lin, Tzu Ping
- Lim, Vivian Yujing
- Toh, Tan Boon
- Yang, Valerie Shiwen
- SpringerLink (Online service)
Other Objects (12)
Targeting epigenetics in sarcomas through EZH2 inhibition
The current landscape of spatial biomarkers for prediction of response to immune checkpoint inhibition
Neurosarcoidosis following Immune Checkpoint Inhibition
Imaging of Bone Sarcomas and Soft-Tissue Sarcomas
Prognostic Metabolite Biomarkers for Soft Tissue Sarcomas Discovered by Mass Spectrometry Imaging
Other rare sarcomas, mixed tumors, genital sarcomas and pregnancy
Evaluating immune checkpoint inhibition in colorectal cancer
Immune checkpoint inhibitors: recent progress and potential biomarkers
Bcl-xL inhibition enhances Dinaciclib-induced cell death in soft-tissue sarcomas
Metabolic landscapes in sarcomas
Prognostic significance of FOXM1 expression and antitumor effect of FOXM1 inhibition in synovial sarcomas
Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors
Targeting epigenetics in sarcomas through EZH2 inhibition
The current landscape of spatial biomarkers for prediction of response to immune checkpoint inhibition
Neurosarcoidosis following Immune Checkpoint Inhibition
Imaging of Bone Sarcomas and Soft-Tissue Sarcomas
Prognostic Metabolite Biomarkers for Soft Tissue Sarcomas Discovered by Mass Spectrometry Imaging
Other rare sarcomas, mixed tumors, genital sarcomas and pregnancy
Evaluating immune checkpoint inhibition in colorectal cancer
Immune checkpoint inhibitors: recent progress and potential biomarkers
Bcl-xL inhibition enhances Dinaciclib-induced cell death in soft-tissue sarcomas
Metabolic landscapes in sarcomas
Prognostic significance of FOXM1 expression and antitumor effect of FOXM1 inhibition in synovial sarcomas
Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors
Targeting epigenetics in sarcomas through EZH2 inhibition
The current landscape of spatial biomarkers for prediction of response to immune checkpoint inhibition
Neurosarcoidosis following Immune Checkpoint Inhibition
Imaging of Bone Sarcomas and Soft-Tissue Sarcomas
Prognostic Metabolite Biomarkers for Soft Tissue Sarcomas Discovered by Mass Spectrometry Imaging
Other rare sarcomas, mixed tumors, genital sarcomas and pregnancy
Evaluating immune checkpoint inhibition in colorectal cancer
Immune checkpoint inhibitors: recent progress and potential biomarkers
Bcl-xL inhibition enhances Dinaciclib-induced cell death in soft-tissue sarcomas
Metabolic landscapes in sarcomas
Prognostic significance of FOXM1 expression and antitumor effect of FOXM1 inhibition in synovial sarcomas